Black Diamond Therapeutics BDTX 深 滬
已收盤 11-06 16:00:00 美东时间
1.735
+0.075
+4.52%
華盛通- 最 高1.79
- 今 開1.65
- 成交量 43.21万股
- 最 低 1.64
- 昨 收 1.66
- 總市值 9968.23万
- 52周最高 4.195
- 市盈率 靜 4.46
- 換手率 0.75%
- 52周最低 1.60
- 委 比 65.38%
- 總股本 5745.37万
- 歷史最高 46.25
- 量 比 0.86
- 振 幅 9.04%
- 歷史最低 1.18
- 每 手 1
- 風險率 0.61%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Clarus Announces $0.025 Per Share Quarterly Dividend
Clarus Corporation announced a quarterly cash dividend of $0.025 per share, payable on November 25, 2026, to stockholders of record as of November 16, 2026. The company, headquartered in Salt Lake City, Utah, specializes in outdoor enthusiast products under brands like Black Diamond, Rhino-Rack, and MAXTRAX. Forward-looking statements in this release are based on current expectations and involve risks and uncertainties.
11-04 21:15
Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates
Relay Therapeutics reported Q3 2026 financial results and updates, including the Phase 3 ReDiscover-2 trial for 2L breast cancer expected to complete enrollment mid-2027. Updated data from the ReInspire trial for zovegalisib in vascular anomalies will be presented at ASH 2026. Shannon Campbell was appointed to lead commercial preparations. The company announced a new mutant-selective TIE2 inhibitor program targeting vascular anomalies. Cash reser...
11-04 21:05
Black Diamond Thera收跌1.69%，成交额89.24万美元
11月3日，Black Diamond Thera（BDTX）收跌1.69%，报1.75美元，成交额89.24万美元，市值1.01亿美元。 行情数据 • 开盘价...
11-03 08:00
Black Diamond Gr Q3 Adj. EPS $0.19 Beats $0.17 Estimate, Sales $159.900M Beat $144.770M Estimate
Black Diamond Gr (TSX:BDI) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.17 by 11.76 percent. This is a 18.75 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $159.900 million wh...
10-30 06:34
Black Diamond Thera收跌10.11%，成交额149.81万美元
10月27日，Black Diamond Thera（BDTX）收跌10.11%，报1.69美元，成交额149.81万美元，市值9709.68万美元。 行情数据...
10-27 07:04
Black Diamond Thera收跌1.15%，成交额92.08万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:07
Anthropic launches Claude for financial advisors after OpenAI's ChatGPT for financial services
Anthropic (ANTHRO) on Monday announced the launch of Claude for financial advisors, a suite of connectors and workflow skills that is expected to help with research, preparation, and documentation tas...
09-15 01:04
Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
Black Diamond Therapeutics announced that its Chief Scientific Officer, Elizabeth Buck, Ph.D., will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026, in New York. The company will also host one-on-one meetings with investors on the same day. Silevertinib, a brain-penetrant fourth-generation EGFR inhibitor, is being developed to target EGFR mutations in NSCLC and GBM. The company ...
09-02 20:01
LodgeLink Showcases Growth Strategy at Canaccord Genuity Conference
Black Diamond ( ($TSE:BDI) ) has shared an announcement. LodgeLink, the technol...
08-08 05:41
Black Diamond Therapeutic Q2 EPS $(0.17) Beats $(0.19) Estimate
Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 10.53 percent increase over losses of $(0.19) per share from the same period last year.
08-06 04:39
